“Baseline and dynamic changes in skeletal muscle mass as predictive biomarkers in patients with metastatic renal cell carcinoma treated with Nivolumab: Predictive Value of Sarcopenia in mRCC”, Radiol Oncol, vol. 59, no. 4, pp. 624–634, Dec. 2025, Accessed: Oct. 01, 2026. Available: https://www.radioloncol.com/index.php/ro/article/view/4685